Skip to content

PTC deepens layoffs as DMD drug faces loss of authorization across Europe – FierceBiotech

PTC deepens layoffs as DMD drug faces loss of authorization across Europe – FierceBiotech

 

PTC Therapeutics has announced that its layoffs will now go deeper and wider than previously announced as European regulators consider halting sales of the company’s Duchenne muscular dystrophy (DMD) drug.A quarter of the company’s employees will now be heading for the exits, with most… 

Read More

Leave a Reply